Reminder - Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2005 Financial Results

neurocrine.com/webcasts/cibcwm/biotech05/12207129. The presentation will be archived until Tuesday, April 19,
2005.
Neurocrine Biosciences, Inc.

conditions syndrome

Company Will Also Present Update

SAN DIEGO, Neurocrine Biosciences, Inc. Participants may access the live Conference Call
by dialing 1-800-540-0559 (U.) or 785-832-1508 (International ) and using the
Conference ID# NBIX. news releases are available through the Company's
website via the Internet at http://www.

diseases conditions

If you are unable to attend the Webcast and would like further information
on this announcement please contact Claudia Jones-Woodworth or Elizabeth
Foster in the Investor Relations Department at Neurocrine Biosciences at
(858) 617-7600.
(Nasdaq: NBIX) announced today that the Company will present at the CIBC
Biotechnology and Specialty Pharmaceuticals Conference on Tuesday, April 5,
2005 at 11:30AM Eastern Daylight Time (EDT) / 8:30AM Pacific Daylight Time
(PDT).neurocrine.

conditions tourette

A replay of the Conference Call will be available
approximately one hour after the conclusion of the call by dialing
1-888-562-2815 (US) or 402-220-7352 (International) and will be archived until
Wednesday, August 17, 2005.cfm
Gary Lyons, President and Chief Executive Officer of Neurocrine will
present an overview of the Company and provide an update on Neurocrine 's broad
development pipeline and research programs.

tourette conditions

The call can also be accessed via the Webcast through
the Company's website at http://www.neurocrine.

Neurocrine Biosciences, Inc. news releases are available through the Company's
website via the Internet at http://www.

diseases shopping

Neurocrine will also host a live conference call and Webcast to discuss
its second quarter financial results and provide a Company update Wednesday
afternoon, August 3, 2005 at 4:30 PM Eastern Daylight Time (EDT) / 1:30 PM
Pacific Daylight Time (PDT). is a product-based biopharmaceutical company
focused on neurological and endocrine diseases and disorders. Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression, diabetes, multiple sclerosis,
irritable bowel syndrome, eating disorders, pain, and autoimmunity. The presentation will be simultaneously webcast and can be accessed on
the Company's website at http://www.neurocrine . A replay will become available approximately three hours
after the live event concludes. Viewers are encouraged to visit the website
approximately 5 minutes prior to the presentation to download or install any
necessary software. Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression, diabetes, multiple sclerosis,
irritable bowel syndrome, eating disorders, pain, and autoimmunity.

health tourette

(Nasdaq: NBIX) announced today that the Company will report second quarter
2005 financial results after the Nasdaq market closes Wednesday , August 3,
2005.S.
Neurocrine Biosciences, Inc.
If you are unable to attend the webcast and would like further information
on this announcement please contact the Investor Relations Department at
Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Jones or
Elizabeth Foster.com

disorders syndrome

com.

Neurocrine Biosciences, Inc.com

Neurocrine Biosciences to Present at the CIBC Biotechnology + Specialty Pharmaceuticals Conference

Live Audio Webcast Tuesday, April 5, 2005

SAN DIEGO, Neurocrine Biosciences, Inc.com or via a link provided by
CIBC World Markets at
http://www.veracast. is a product-based biopharmaceutical company
focused on neurological and endocrine diseases and disorders.